Global Needle Free Injection Systems Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2023 –2030 |
 Market Size (Base Year) |
USD 156.00 Million |
 Market Size (Forecast Year) |
USD 670.77 Million |
 CAGR |
% |
| Major Markets Players |
|
>全球无针注射系统市场，按类型（液体无针注射器、弹丸/储库无针注射器、粉末无针注射器）、产品（可填充无针注射器、预填充无针注射器）、技术（喷射无针注射器、弹簧全球无针注射器、激光供电无针注射器、振动无针注射器）、可用性（一次性无针注射器、可重复使用无针注射器）、注射部位（皮下注射器、肌肉内注射器、皮内注射器）、应用（疫苗输送、胰岛素输送、肿瘤学、疼痛管理、其他）、最终用户（医院和诊所、家庭护理机构、研究实验室、制药和生物技术公司、其他）划分 - 行业趋势和预测到 2030 年。
无针注射系统市场分析和规模
无针注射系统用于将液体制剂、药物和疫苗注射到患者体内，而无需用传统针头刺穿皮肤。近年来，对这些系统的需求大幅增加，因为它们可以改善对疫苗的免疫反应、消除针头风险并降低医疗成本。
Data Bridge Market Research 分析，无针注射系统市场在 2022 年为 1.56 亿美元，预计到 2030 年将达到 6.7077 亿美元，预计在预测期内的复合年增长率为 20.00%。这表明了市场价值。由于对药物管理的需求不断增长，液体无针注射器在无针注射系统市场类型细分市场中占据主导地位。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的洞察外，Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。
无针注射系统市场范围和细分
|
报告指标 |
细节 |
|
预测期 |
2023 至 2030 年 |
|
基准年 |
2022 |
|
历史岁月 |
2021 (可定制为 2015-2020) |
|
定量单位 |
收入（百万美元）、销量（单位）和定价（美元） |
|
涵盖的领域 |
By Type (Liquid-Based Needle-Free Injectors, Projectile/Depot-Based Needle-Free Injectors, Powder-Based Needle Free Injectors), Product (Fillable Needle-Free Injectors, Prefilled Needle-Free Injectors), Technology (Jet-Based Needle-Free Injectors, Spring Global Needle Free Injectors, Laser-Powered Needle-Free Injectors, Vibration-Based Needle-Free Injectors), Usability (Disposable Needle-Free Injectors, Reusable Needle-Free Injectors), Site of Delivery (Subcutaneous Injectors, Intramuscular Injectors, Intradermal Injectors), Application (Vaccine Delivery, Insulin Delivery, Oncology, Pain Management, Other), End User (Hospitals and Clinics, Home Care Settings, Research Laboratories, Pharmaceutical and Biotechnological Companies, Other) |
|
Countries Covered |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
|
Market Players Covered |
PharmaJet (U.S.), Portal Instruments (U.S.), Medical International Technology, Inc (U.S.), NuGen Medical Devices (Canada), Crossject SA (U.S.), Antares Pharma (U.S.), 3M (U.S.), Injex Pharma AG(Germany), NovaXS Biotech (U.S.) and INVIO Pharmaceutical Inc. (U.S.) |
|
Market Opportunities |
|
Market Definition
Needle-free injection systems are used to administer liquid formulations, drugs, and vaccines into patients without piercing the skin with a conventional needle. The demand for these systems has increased considerably in the recent years as they improve immune response to vaccines, eliminate risks of needles, and reduce healthcare costs. However, lack of skilled professionals and the restricted use of needle-free injection systems for intravenous administration impede the market growth.
Global Needle Free Injection Systems Market Dynamics
Drivers
- Growing Prevalence of Patients and Promote Treatment to Boost Market Growth
Drugs are supposed to be administered into the body without using injection needle as conveniently and painlessly as feasible. Needle free injection systems used to give medications for the treatment of many different conditions. It is estimated that over the forecasted period, the value of the needle free injection system market would increase due to the increased prevalence of chronic diseases including osteoporosis and diabetes.
Needle-free injection systems are novel ways to introduce various medicines into patients without piercing the skin with a conventional needle
- Research and Development Proficiencies
Rising expenditure for research and development proficiencies especially in the developed and developing economies pertaining to medical devices and advance products will further create lucrative market growth opportunities. Research and development proficiencies being conducted to develop medical instruments is also expected to drive the market growth rate.
When developing drug-delivery device systems, it is important to identify equipment that can efficiently perform all of the required product testing while intelligently capturing and evaluating the test data in accordance with government regulations. The test system must also be flexible and modular enough that manufacturers can change and add functionality over time.
- Increasing Government Initiatives for Improving Healthcare
Healthcare sector is increasing rapidly, which have a significant impact on public health as well as economic activity. The increasing government initiatives for advance systems enhance the demand for the Needle Free Injection Systems. The use of Needle Free Injection Systems is increasing in households, hospitals and independent laboratory.
When developing and mass producing such devices, manufacturers usually perform a combination of testing to government-regulated standards and internal quality testing to ensure efficacy of the device. Internal quality testing is often necessary because the international standards committees cannot always amend testing standards as quickly as the device technology evolves.
Opportunities
- Increasing Demand for Painless Drug Delivery
Needle-free injections provide a painless alternative to traditional needle injections, which can be particularly beneficial for patients who have a fear of needles or experience discomfort during injections. The market is expected to grow as more individuals seek painless drug delivery options.
- Expansion of Vaccination Programs
Needle-free injection systems are also being widely adopted in vaccination programs, particularly in developing countries. They offer advantages such as reduced cross-contamination risk and improved vaccine coverage. As global vaccination programs continue to expand, the demand for needle-free injection devices is expected to rise.
Restraints/Challenges
- Limited Awareness and Acceptance
The needle-free injection technology is still relatively new and not as widely known or accepted compared to traditional needle injections. Healthcare providers and patients may have concerns about the efficacy, safety, and reliability of these devices, which could hinder their adoption.
- High Cost of Products
Needle-free injection devices can be more expensive compared to traditional needle-based injection systems. The initial investment and ongoing maintenance costs associated with these devices may limit their adoption, particularly in low-income regions or healthcare settings with budget constraints.
This Needle Free Injection Systems market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global needle free injection systems market contact Data Bridge Market Research for an Analyst Brief, our team will help you make an informed market decision to achieve market growth.
Recent Developments
- In March 2022, NovaXS Biotech launch injection therapy needle-free such as NovaXS Biotech wants to make injection therapy needle-free
- In December 2021, PharmaJet partner, Nykode Therapeutics announces phase 1/2 clinical trial with next-generation DNA-based COVID-19 vaccine candidates
- In August 2021, PharmaJet partner Zydus Cadila announced Emergency Use Authorization approval for worlds first plasmid DNA COVID-19 vaccine deliver via needle-free injection
Global Needle Free Injection Systems Market Scope
The Needle Free Injection Systems market is segmented on the type, product, technology, usability, site of delivery, application and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Liquid-Based Needle-Free Injectors
- Projectile/Depot-Based Needle-Free Injectors
- Powder-Based Needle Free Injectors
Product
- Fillable Needle-Free Injectors
- Prefilled Needle-Free Injectors
Technology
- Jet-Based Needle-Free Injectors
- Spring Global Needle Free Injectors
- Laser-Powered Needle-Free Injectors
- Vibration-Based Needle-Free Injectors
Usability
- Disposable Needle-Free Injectors
- Reusable Needle-Free Injectors
Site of Delivery
- Subcutaneous Injectors
- Intramuscular Injectors
- Intradermal Injectors
Application
- Vaccine Delivery
- Insulin Delivery
- Oncology
- Pain Management
- Other
End User
- Hospitals and Clinics
- Home Care Settings
- Research Laboratories
- Pharmaceutical and Biotechnological Companies
- Other
Global Needle Free Injection Systems Market Regional Analysis/Insights
The global Needle Free Injection Systems market is analysed and market size insights and trends are provided by country, type, product, technology, usability, site of delivery, application and end user as referenced above.
无针注射系统市场报告涵盖的国家包括北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。
北美有望主导全球无针注射系统市场，因为该地区拥有强大的医疗设施基础、主要市场参与者的强大存在增加了慢性病病例，而且该地区的研究活动数量不断增加。
预计亚太地区将在 2023 年至 2030 年的预测期内实现显着增长，这得益于政府加强宣传力度、该地区研究活动不断增多、拥有大量未开发市场、人口众多以及对优质医疗服务的需求不断增长。
报告的国家部分还提供了影响单个市场影响因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的大量或稀缺竞争而面临的挑战、国内关税的影响和贸易路线。
医疗保健基础设施增长安装基础和新技术渗透
全球无针注射系统市场还为您提供详细的市场分析，包括每个国家/地区资本设备医疗保健支出的增长、全球无针注射系统市场不同类型产品的安装基数、使用生命线曲线的技术的影响以及医疗保健监管情景的变化及其对全球无针注射系统市场的影响。数据适用于 2015-2020 年的历史时期。
竞争格局和全球无针注射系统市场份额分析
全球无针注射系统市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对全球无针注射系统市场的关注有关。
全球无针注射系统市场的一些主要参与者包括：
- PharmaJet（美国）
- Portal Instruments（美国）
- 医疗国际技术有限公司（美国）
- NuGen 医疗设备（加拿大）
- Crossject SA（美国）
- Antares Pharma（美国）
- 3M（美国）
- Injex Pharma AG（德国）
- NovaXS Biotech（美国）
- INVIO Pharmaceutical Inc.（美国）
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
